Can mucoid Pseudomonas aeruginosa be eradicated in children with cystic fibrosis?

Pediatric Pulmonology

Volumn 45, Issue 6, 2010, Pages 566-568

  McPherson, Helen ^a   Rosenthal, Mark ^b   Bush, Andrew ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Aspergillus fumigatus; Colistin; Nebulized antibiotics

Indexed keywords

ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CYSTIC FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; COLISTIN; CYSTIC FIBROSIS; FEMALE; GENTAMICINS; HUMANS; LONGITUDINAL STUDIES; MALE; NEBULIZERS AND VAPORIZERS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 77953299585     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21220     Document Type: Article

References (10)

1. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996;60:539-574. (Pubitemid 26303478)
2. Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull 2002;61:81-96.
3. Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
4. Li Z, Kosorok MR, Farrell PM, Laxova A, West SEH, Green CG, Collins J, Rock MJ, Splaingard ML. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293: 581-588.
5. Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang S, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 2006;116:436-446.
6. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW, Guidelines for the diagnosis of cystic fibrosis in newborns through older adults. J Paediatr 2008;153:S4-S14
7. Clinical Guidelines - Care of Children With CF. Royal Brompton Hospital, 2007 (available at) www.rbht.nhs.uk/childrencf.
8. Guiterrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Roberston CF, Phelan PD, Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 2001;17:281-286.
9. Valerius NH, Koch C, Hoiby N, Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-726.
10. Ratjen F, Doring G, Nikolaizik WH, Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001;358:983-984.